ArticleTranslational lung cancer research2026
Impact of pleural lavage fluid volume on perioperative outcomes in non-small cell lung cancer patients undergoing video-assisted thoracoscopic lobectomy: a randomized controlled trial.
Article in Translational lung cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The optimal volume for pleural lavage during lung cancer surgery remains controversial, despite its recognized importance in thoracic cavity decontamination, tumor cell clearance, and prevention of postoperative complications. This study assessed the impact of varying lavage volumes on perioperative outcomes in non-small cell lung cancer (NSCLC) patients, with the objective of establishing evidence-based procedural guidelines. Methods: Participants underwent lobectomy for NSCLC were randomly assigned to receive either 1,000 or 250 mL of pleural lavage before chest closure. The primary outcome was overall fever rates, and secondary outcomes included complication rates, drainage parameters, and length of hospital stay. Results: A total of 415 patients were screened, and 406 were randomized to either the 1,000 mL (n=206) or 250 mL (n=200) groups. Postoperative fever (≥37.3 ℃) occurred in 23.08% of the 1,000 mL group and 17.01% of the 250 mL group (P=0.17). The fever rates at ≥38 ℃ were similar between groups (5.13% Conclusions: A volume of 250 mL pleural lavage demonstrated comparable efficacy to 1,000 mL in controlling postoperative fever and complications, while showing trends toward reduced resource utilization (shorter surgery duration, lower drainage volume and cost). Trial Registration: The trial protocol was registered with the Chinese Clinical Trial Registry (registration number: ChiCTR1900021950) before patient enrollment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.